CStone Pharmaceuticals (2616.HK)

HKD 2.65

(-0.75%)

Long Term Debt Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual long term debt in 2023 was 224.13 Million CNY , down -7.14% from previous year.
CStone Pharmaceuticals's latest quarterly long term debt in 2024 Q1 was 228.3 Million CNY , up 7.18% from previous quarter.
CStone Pharmaceuticals reported annual long term debt of 241.37 Million CNY in 2022, up 85.31% from previous year.
CStone Pharmaceuticals reported annual long term debt of 130.25 Million CNY in 2021, up 79.54% from previous year.
CStone Pharmaceuticals reported quarterly long term debt of 228.3 Million CNY for 2024 Q2, down 0.0% from previous quarter.
CStone Pharmaceuticals reported quarterly long term debt of 177.73 Million CNY for 2023 Q1, down -26.36% from previous quarter.

Annual Long Term Debt Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Long Term Debt of CStone Pharmaceuticals (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	224.13 Million CNY	-7.14%
2022	241.37 Million CNY	85.31%
2021	130.25 Million CNY	79.54%
2020	72.54 Million CNY	0.0%
2019	- CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	228.3 Million CNY	7.18%
2024 Q2	228.3 Million CNY	0.0%
2023 Q1	177.73 Million CNY	-26.36%
2023 Q3	224.13 Million CNY	26.11%
2023 Q2	177.73 Million CNY	0.0%
2023 FY	224.13 Million CNY	-7.14%
2023 Q4	213 Million CNY	-4.97%
2022 Q1	162.47 Million CNY	24.74%
2022 FY	241.37 Million CNY	85.31%
2022 Q4	241.37 Million CNY	0.0%
2022 Q3	241.37 Million CNY	48.56%
2022 Q2	162.47 Million CNY	0.0%
2021 Q4	130.25 Million CNY	0.0%
2021 Q3	130.25 Million CNY	57.31%
2021 FY	130.25 Million CNY	79.54%
2021 Q1	82.79 Million CNY	14.13%
2021 Q2	82.79 Million CNY	0.0%
2020 Q1	23.89 Million CNY	0.0%
2020 Q3	72.54 Million CNY	203.6%
2020 Q2	23.89 Million CNY	0.0%
2020 FY	72.54 Million CNY	0.0%
2020 Q4	72.54 Million CNY	0.0%
2019 Q3	- CNY	-100.0%
2019 FY	- CNY	0.0%
2019 Q4	- CNY	0.0%
2019 Q2	1.4 Million CNY	0.0%
2019 Q1	1.4 Million CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q1	- CNY	0.0%
2018 Q3	- CNY	0.0%
2018 FY	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 FY	- CNY	0.0%

Peer Long Term Debt Comparison of CStone Pharmaceuticals

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-632.18%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	94.755%